Overview
- 82 inspections across 80 sites are on record.
- 8 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-03.
At a glance
Inspections
82
Sites
80
Observations
8
Career since
Dec 2020
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Deciphera Pharmaceuticals, LLC | 3 Jun 2026 | Human Drugs | |
| Lakshmi S. Nayak, MD | 15 May 2026 | Human Drugs | |
| Pablo Rojo Conejo, MD. | 24 Apr 2026 | Biologics | |
| Rafael Del Rio Villegas, MD, PhD | 17 Apr 2026 | Human Drugs | |
| Cerveau Technologies, Inc. | 26 Mar 2026 | Human Drugs |
Sites inspected
Deciphera Pharmaceuticals, LLCWaltham, United States1 insp.
Lakshmi S. Nayak, MDBoston, United States1 insp.
Pablo Rojo Conejo, MD.Madrid, Spain1 insp.
Rafael Del Rio Villegas, MD, PhDMadrid, Spain1 insp.
Cerveau Technologies, Inc.Bedford, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Matthew C Watson5 shared
Meredith L Miller3 shared
Michael Serrano3 shared
Victoria M Daddeo3 shared
Agata E Libera1 shared
Chantae D Mitchell1 shared
Kent A Conforti1 shared
Full investigator report
Get the verbatim findings behind Jose A Torres' 8 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site